CardioVascular and Interventional Radiology最新文献

{"title":"Percutaneous Cryoablation of an Intrathoracic Kidney Tumour within a Bochdalek Hernia.","authors":"Leon S K Yao, Hao Xiang","doi":"10.1007/s00270-026-04534-z","DOIUrl":"10.1007/s00270-026-04534-z","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2172-2175"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148535315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transhepatic Endovascular Embolization of a Splenic Vein Pseudoaneurysm after Central Pancreatectomy.","authors":"Pelin Saglik Gunday, Irem Islek, Mehmet Seker, Onur Yaprak, Cengiz Erol","doi":"10.1007/s00270-026-04554-9","DOIUrl":"10.1007/s00270-026-04554-9","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2182-2185"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148618417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Arterial Perfusion Changes Following Transcatheter Arterial Microembolization for Hand Joint Pain.","authors":"Shinichi Iwakoshi, Katsutoshi Horiuchi, Yuki Suenaga, Masatoshi Ikeno, Takeshi Sato, Kenji Kawamura, Toshihiro Tanaka","doi":"10.1007/s00270-026-04437-z","DOIUrl":"10.1007/s00270-026-04437-z","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2199-2201"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147697186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Answering a Practical Question After Yttrium-90 Radioembolization: SPECT/CT or PET/CT?","authors":"Mahdi Zirakchian Zadeh","doi":"10.1007/s00270-026-04498-0","DOIUrl":"10.1007/s00270-026-04498-0","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2180-2181"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148210120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Commentary on: Uterine Artery Embolization Using Gelatin Sponge Particles in Patients with Symptomatic Uterine Fibroids: A Systematic Review and Meta-analysis.","authors":"Jean-Pierre Pelage","doi":"10.1007/s00270-026-04480-w","DOIUrl":"10.1007/s00270-026-04480-w","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2002-2003"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148270571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aspartate Aminotransferase to Platelet Index (APRI) as a Prognostic Factor for Overall Survival After TARE Y90 Resin Microspheres in Primary Liver Cancer Patients: Results from the European, Prospective Observational Study CIRT.","authors":"Niklaus Schaefer, Dirk Arnold, Niels de Jong, Milan Geyer, Maria Urdaniz, Thomas Helmberger","doi":"10.1007/s00270-026-04483-7","DOIUrl":"10.1007/s00270-026-04483-7","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the prognostic value of the aspartate aminotransferase-to-platelet ratio index (APRI) for overall survival (OS) after transarterial radioembolization (TARE) in patients with intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) from the prospective study CIRT (CIRSE study on SIR-Spheres Therapy).</p><p><strong>Materials and methods: </strong>Adult patients treated with TARE Y-90 were included. Baseline, laboratory, treatment, and follow-up data were collected prospectively. Receiver operating characteristic analysis was used to determine optimal APRI cut-offs. OS from the date of TARE was analysed using Kaplan-Meier. Propensity score matching and multivariable Cox regression analyses were performed.</p><p><strong>Results: </strong>103 ICC and 377 HCC patients were analysed. Most patients had ECOG 0 (58.3%/61.3%) or 1 (31.1%/31.8%) in the ICC and HCC groups, respectively. Median APRI was 0.5 (IQR: 0.3-0.8) in ICC and 0.8 (IQR: 0.4-1.4) in HCC. Higher APRI values were associated with significantly shorter OS in both cohorts using different thresholds (ICC: APRI > 0.4; HCC: APRI > 0.7). These associations remained significant after propensity score matching and multivariable analysis. APRI was an independent prognostic factor for OS in both ICC (95% CI 1.25-5.23; p = 0.010) and HCC (95% CI 1.04-2.06; p = 0.028). The identified APRI cut-offs were associated with survival differences when body surface area (BSA) and modified BSA dosimetry were used, but not with partition model dosimetry.</p><p><strong>Conclusion: </strong>APRI may be a promising, easily accessible prognostic biomarker for OS after TARE in ICC and HCC patients. Its prognostic value may be influenced by tumour type and counteracted by dosimetry method, supporting further investigation on this topic. Trial registration NCT02305459.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2064-2071"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148041247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictors of Recurrence Following Bronchial Artery Embolisation (BAE) for Haemoptysis: A Systematic Review and Evidence Synthesis Analyses Using SWiM Guidelines.","authors":"Diya Sethi, Tejas Ramnath Iyer, Sinan Abu-Al-Timen","doi":"10.1007/s00270-026-04520-5","DOIUrl":"10.1007/s00270-026-04520-5","url":null,"abstract":"<p><strong>Purpose: </strong>This systematic review aims to identify independent etiological, anatomical, and procedural predictors of recurrent haemoptysis following Bronchial artery embolisation (BAE) using a Synthesis Without Meta-analysis (SWiM) framework.</p><p><strong>Materials and methods: </strong>PubMed, Cochrane, and Scopus were systematically searched in February 2026 for cohort studies analysing post-BAE haemoptysis recurrence in line with PRISMA guidelines. Data were synthesised using a SWiM approach as clinical heterogeneity and intra-cohort mixing of embolic agents precluded a meta-analysis. Multivariable evidence was prioritised over univariable results to determine the independent direction-of-effect, using a SWiM vote-counting approach. GRADE framework was used to assess the certainty of evidence.</p><p><strong>Results: </strong>Sixty-five studies involving 12,143 patients met the inclusion criteria. Across multivariable evidence, systemic-pulmonary shunts, non-bronchial systemic collaterals (NBSCs), pleural thickening, bronchiectasis, aspergillosis, prior history of haemoptysis, positive sputum culture, and abnormal platelet indices were identified as positive independent predictors of recurrence. Conversely, active tuberculosis, pulmonary malignancy, post-tuberculous sequelae, high-volume haemoptysis, cystic fibrosis, and concurrent anticoagulant use were neutral predictors. Analysis of embolic agents did not demonstrate a clear superiority of any specific agent.</p><p><strong>Conclusion: </strong>Chronic parenchymal destruction and systemic-pulmonary shunts are primary factors in long-term BAE failure due to haemoptysis recurrence as compared to presentation characteristics or embolic agents. Thorough angiographic investigation for cryptic collaterals and post-procedural management of underlying diseases is important for the efficacy of BAE.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"1963-1976"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148403769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Results from the Pan-European CIEMAR study: Local Tumour Control After Microwave Ablation of Colorectal Liver Metastases and Exploratory Associations with Ablation Margins and Confirmation Software.","authors":"Martijn Meijerink, Hannah Schulz, Asmund A Fretland, Reto Bale, Dirk Arnold, Tugsan Balli, Carlo Gazzera, Stefan Staettner, Thomas Helmberger, Thomas Vogl, Anna Kafloula, Bleranda Zeka, Maria Urdaniz, Franco Orsi, Philippe L Pereira","doi":"10.1007/s00270-026-04578-1","DOIUrl":"10.1007/s00270-026-04578-1","url":null,"abstract":"<p><strong>Purpose: </strong>The CIRSE Emprint Microwave Ablation (MWA) Registry (CIEMAR) was designed to evaluate real-world effectiveness of MWA for colorectal liver metastases (CRLM). This analysis reports on local tumour control and includes post-hoc analyses of ablation margin size and confirmation software use.</p><p><strong>Materials and methods: </strong>Patients were eligible if MWA was indicated as part of a curative-intent strategy for ≤9 local treatment-naïve CRLM measuring ≤3 cm, with no extrahepatic disease except ≤5 lung nodules. Baseline, treatment and follow-up data from September 2019 to December 2025 were analysed. Ablation margin categories were reported locally according to centre-specific practice. The primary endpoint was the 1-year local tumour control rate after the last MWA.</p><p><strong>Results: </strong>In total, 491 patients with 1083 CRLM from 30 sites in 11 countries were included. Reported margins were <5mm (12.3%), 5-10mm (35.5%) or >10mm (44.5%); for 1.5% and 6.2% of lesions, ablation was incomplete and data were missing, respectively. The 1-year local tumour control rate was 88.9% (95% CI 83.2-94.6) on a per-lesion basis and 81.2% (95% CI 77.2-84.6) on a per-patient basis. Larger margins were independently associated with lower odds of local failure (5-10 mm: OR 0.30; >10 mm: OR 0.10; both p<0.01 vs <5 mm). Use of confirmation software was associated with wider reported margins (p<0.001).</p><p><strong>Conclusion: </strong>MWA for CRLM achieved high 12 month local tumour control. These findings support routine verification that adequate ablation margins have been achieved, while exploratory association between confirmation software use and wider margins warrants further confirmation.</p><p><strong>Trials registration: </strong>NCT03775980.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2004-2017"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148900187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anxiety-Depressive Symptoms and Pain Response Following Venous Interventions for Venous-Origin Chronic Pelvic Pain Related to Pelvic Venous Disorders.","authors":"Xiangtao Li, Zongxu Jing, Shuo Shan, Lu Hu, Xiaoyun Luo","doi":"10.1007/s00270-026-04539-8","DOIUrl":"10.1007/s00270-026-04539-8","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate whether baseline anxiety-depressive symptom burden is associated with 3-month pain response after venous interventions in women with venous-origin chronic pelvic pain related to pelvic venous disorders (PeVD).</p><p><strong>Materials and methods: </strong>This single-center observational cohort study was a retrospective analysis of prospectively collected institutional registry data. A total of 103 women with symptomatic PeVD and venous-origin chronic pelvic pain who underwent venous intervention were included. Pain was assessed using a 0-10 numerical rating scale for average pelvic pain, disease-specific quality of life using the Pelvic Varicose Veins Questionnaire (PVVQ), and anxiety-depressive symptoms using the Hospital Anxiety and Depression Scale (HADS) and Beck Depression Inventory (BDI). Outcomes were assessed at baseline and 3 months. Good pain response was defined as a ≥ 50% reduction in VAS score. Spearman correlation, multivariable linear regression, and Firth bias-reduced logistic regression were used.</p><p><strong>Results: </strong>Baseline VAS, PVVQ, BDI, HADS-A, and HADS-D scores were 7.41 ± 0.90, 63.77 ± 11.76, 16.95 ± 8.70, 10.97 ± 3.15, and 8.94 ± 3.55, respectively. Clinically relevant anxiety symptoms (HADS-A ≥ 8), depressive symptoms (HADS-D ≥ 8), and BDI-defined depressive symptoms (BDI ≥ 14) were present in 80 (77.7%), 63 (61.2%), and 61 (59.2%) patients, respectively. At 3 months, VAS decreased to 2.46 ± 2.55, PVVQ to 33.47 ± 17.74, BDI to 8.60 ± 9.55, HADS-A to 4.87 ± 4.79, and HADS-D to 4.90 ± 4.74 (all P < 0.001). Good pain response occurred in 80 patients (77.7%). Baseline BDI correlated with VAS improvement percentage (ρ = - 0.792, 95% CI - 0.855 to - 0.707, P < 0.001). After adjustment for age and baseline VAS, each one-point increase in baseline BDI was associated with a 2.98-percentage-point lower VAS improvement (95% CI - 3.38 to - 2.57, P < 0.001) and higher odds of poor pain response (adjusted OR 1.94, 95% CI 1.21-3.13, P = 0.006).</p><p><strong>Conclusion: </strong>Venous intervention was associated with significant 3-month improvement in pain, disease-specific quality of life, and anxiety-depressive symptoms. Greater baseline depressive symptom burden was associated with less favorable short-term pain response. These findings are exploratory and require validation in multicenter studies with standardized PeVD phenotyping and longer follow-up.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"2116-2126"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148535305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Efficacy and Safety of Transarterial Therapies for Unresectable Neuroendocrine Liver Metastases: A Systematic Review.","authors":"Hugo C Temperley, Richard Grainger, Omar Abu Saadeh, Niall J O'Sullivan, Benjamin M Mac Curtain, Julian Soares, Nicholas Fidelman, Michael E Kelly, Kevin P Sheahan","doi":"10.1007/s00270-026-04607-z","DOIUrl":"10.1007/s00270-026-04607-z","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy and safety of transarterial embolisation, conventional and drug-eluting-bead chemoembolisation, and radioembolisation in adults with unresectable neuroendocrine liver metastases.</p><p><strong>Materials and methods: </strong>Five databases were searched from inception to June 2026 for studies comparing two or more transarterial modalities. Study quality was appraised using the Newcastle-Ottawa Scale or the Cochrane Risk of Bias 2 tool. Because outcome reporting was heterogeneous, findings were synthesised narratively; pooling was undertaken only where two or more studies reported per-arm binary event counts.</p><p><strong>Results: </strong>Fifteen comparative studies including 1,454 patients were identified, 12 of them retrospective. Pooling was feasible for two safety outcomes only, each drawing on two studies: post-embolisation syndrome after chemoembolisation versus embolisation (odds ratio 2.17, 95% confidence interval 0.68-7.00) and severe adverse events after chemoembolisation versus radioembolisation (odds ratio 1.27, 95% confidence interval 0.58-2.79). Adjusted survival estimates with confidence intervals were reported in only four studies. Tumour grade and hepatic tumour burden were the most consistent prognostic factors. No modality showed a consistent survival advantage; radioembolisation offered shorter hospital stays, and evidence for drug-eluting-bead chemoembolisation remained limited amid hepatobiliary toxicity concerns.</p><p><strong>Conclusion: </strong>No transarterial modality has been shown to confer a consistent survival advantage, but the evidence is predominantly retrospective and too heterogeneous to establish equivalence. Selection should be individualised within a multidisciplinary team, accounting for disease burden, tumour biology, treatment goals, and safety. Adequately powered prospective trials remain an unmet priority.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"1922-1934"},"PeriodicalIF":3.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148918259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}